


Xuanzhu Biopharmaceutical Revenue
Pharmaceutical Manufacturing • Zhengding, Hebei, China • 21-50 Employees
Xuanzhu Biopharmaceutical revenue & valuation
| Annual revenue | $3,251,090 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $10,500,000 |
| Total funding | $96,100,000 |
Key Contacts at Xuanzhu Biopharmaceutical
Mei Xu Phd
Director, Overseas Business Development
莹 陈
Medical Director
Deyan Hou
Senior Director Business Development
Krista Xie
Project Management Director
Company overview
| Headquarters | 高新区太行大街769号京津冀协作创新示范园203C507, 石家庄市, 河北省 570000, CN |
| Phone number | +8653180989300 |
| Website | |
| NAICS | 3254 |
| Keywords | 科研, 化学, 合成, 新药研发 |
| Founded | 2002 |
| Employees | 21-50 |
| Socials |
Xuanzhu Biopharmaceutical Email Formats
Xuanzhu Biopharmaceutical uses 2 email formats. The most common is {2char} (e.g., {2char}@xuanzhubio.com), used 66.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{2char} | {2char}@xuanzhubio.com | 66.7% |
{last name}{first initial} | doej@xuanzhubio.com | 33.3% |
About Xuanzhu Biopharmaceutical
Xuanzhu Biopharmaceutical Co., Ltd. is an international research and development (R&D) enterprise of innovative drugs. Founded in 2002 with the registered capital of 100 million yuan,Xuanzhu Biopharm is focused on R&D of new chemical entities. It is a wholly-owned subsidiary and innovative drug research institute of Sihuan Pharmaceutical Holdings Group Ltd (Sihuan Pharma). Sihuan Pharma, listed in Hong Kong (stock code: 00460.HK) on October 28, 2010, has developed into a multi-functional pharmaceutical group company, covering R&D, manufacture and corresponding sales. We work on seven cutting-edge therapeutic areas, such as antibiotics, cardiovascular diseases, oncology and diabetes. So far, multiple technology platforms have been established, including New Drug Design and Synthesis Center, Center for Pharmacology, Center for Drug Metabolism and Pharmacokinetics, Center for Early Safety Assessment & Research, API Scale-Up Center, Formulation R&D Center. Besides, a complete system of new drug R&D has been set up, covering a wide spectrum from structure design of new drug to drug screening and evaluation for CRCD, from IND application to new drug application. Xuanzhu Biopharm has been in a leading position in the field of new drug discovery and development in China and is committed to building a world-class innovative drug research platform.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Xuanzhu Biopharmaceutical has 8 employees across 4 departments.
Departments
Number of employees
Funding Data
Explore Xuanzhu Biopharmaceutical's funding history, including investment rounds, total capital raised, and key backers.
Xuanzhu Biopharmaceutical Tech Stack
Discover the technologies and tools that power Xuanzhu Biopharmaceutical's digital infrastructure, from frameworks to analytics platforms.
Web servers
Analytics
JavaScript libraries
JavaScript libraries
Programming languages
JavaScript libraries
JavaScript graphics
Frequently asked questions
4.8
40,000 users



